The election is over, but the pharmacy policy fight isn’t. From ECAPS and PBM reform to drug pricing and patient access, the next several weeks could be critical for pharmacy. In this staff blog, Doug Huynh, APhA Director of Congressional Affairs, breaks down what pharmacists should watch as Congress heads into 2027.

A patient seeking relief may not recognize the risks of a product within easy reach. Brigid K. Groves, PharmD, MS, APhA’s Vice President, Professional Affairs, shares why kratom and concentrated 7-OH products deserve pharmacists’ attention and how a simple conversation can help protect patients from harm.

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.